A new advancement in stem cell differentiation has been developed by UNSW Australia researchers. The technique utilizes autologous stem cells treated with a series of growth factors to promote cell plasticity. The mixture is then inserted into damaged tissues, promoting growth and healing.
A new method of stem cell harvesting was developed by a group of Australian researchers. The technique is less invasive than current methods and reduces unwanted side effects. Existing harvesting procedures are lengthy and require injections of growth factors to boost stem cell numbers. Growth factors can cause unpleasant side effects like bone pain and spleen enlargement for some patients while other patients don’t respond well impacting stem cell recovery.
Researchers at the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine have investigated the impact of mesenchymal stem cell exosomes in the treatment of chronic non-healing wounds. These conditions affect 6.5 million people with diabetes and paraplegia in the Unites States alone, at an estimated treatment cost of $25 billion per year.
A team of Italian researchers have injected autologous [the patient’s own] mesenchymal stem cells [MSCs] into patients suffering from digital ulcers (DU). The ulcers are brought about by systemic sclerosis (SSc), a connective tissue disease that progressively degrades blood vessels, causing havoc across multiple organ systems. DUs are slow to heal and are often unresponsive to therapies in individuals with SSc.
For over 10 million Americans, osteoporosis presents a chronic, degenerative, and complex problem, with few current therapeutic options to promote bone growth. A team of researchers from Loma Linda University and the Jerry L. Pettis Memorial VA Medical Center in California have reversed the bone-degrading disease of osteoporosis in an animal model using hematopoietic stem cells [HSCs]. The research offers yet another development in our current understanding and capability for practical application in the stem cell field. Now, after having identified specific growth factors related to bone growth and proliferation, stem cell therapy is thought to holds great promise in reversing bone weakness and ultimately, morbidity and mortality.